[February 14, 2012]

Research and Markets: Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

Research and Markets (http://www.researchandmarkets.com/research/3cf237/switzerland_in_vit) has announced the addition of Global Markets Direct's new report "Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017" to their offering.

Switzerland In Vitro Diagnostics Investment Opportunities, nalysis and Forecasts to 2017, a new report by Global Markets Direct, provides key market data on the Switzerland In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

• Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
• Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the Switzerland In Vitro Diagnostics market.

Companies Mentioned:

• Siemens (News - Alert) Healthcare
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Beckman Coulter, Inc.
• bioMerieux S.A.
• Sysmex Corporation
• Alere Inc.
• Ortho-Clinical Diagnostics Inc.
• Becton, Dickinson and Company
• HORIBA, Ltd.
• DIAGNOSTICA STAGO, Inc.
• Thermo Fisher Scientific Inc.
• Phadia AB
• DiaSorin S.p.A
• Grifols, S.A.
• Qiagen N.V.
• Gen-Probe Incorporated
• Immucor, Inc.
• Hologic, Inc.
• Life Technologies Corporation
• PerkinElmer, Inc.
• Danaher (News - Alert) Corporation

For more information visit http://www.researchandmarkets.com/research/3cf237/switzerland_in_vit

[ Back To TMCnet.com's Homepage ]